Health News (Reuters)

Lou Gehrig's disease may affect the mind

(Reuters Health) - Even though the neurologic disorder known as Lou Gehrig's disease has long been thought to ravage the body while leaving the mind untouched, a new study suggests that the condition may also affect thinking skills and behavior.

Doctors offer advice for insomnia

(Reuters Health) - People who have trouble falling asleep and staying asleep may want to seek advice from a doctor and avoid long-term use of sleeping pills, medical experts advise.

FDA considering ban on flavored e-cigarettes

The U.S. Food and Drug Administration is considering a ban on flavored e-cigarettes in response to an "epidemic" of young people using e-cigarettes, the agency's leader said on Wednesday.

EU officials clash with Chinese firm on drug factory inspection

European medicines regulators have issued a notice that an ingredient for a generic brain cancer drug made in China does not meet manufacturing standards, after inspectors were refused entry to a factory run by Jiangsu Yew Pharmaceutical Co. Ltd.

Vital Therapies shares dive as liver system fails trial

U.S. biotech firm Vital Therapies Inc said it will explore strategic options after its liver disease treatment failed to meet the main goal of a late-stage study, driving its shares down more than 70 percent on Wednesday.

Galapagos shares soar on $4-6 billion hopes for new drug

Strong results for an experimental drug that promises to disrupt the rheumatoid arthritis market lifted shares in Belgian-Dutch firm Galapagos to an all-time high on Wednesday, as analysts forecast multibillion-dollar sales.

Teva to hold Indivior generic drug launch pending U.S. ruling

Teva Pharmaceuticals has agreed to hold off launching its knock-off version of Indivior Plc's blockbuster opioid addiction drug until the resolution of a U.S. Court case on another generic rival, Indivior said on Wednesday.

Pages